News

Mural Oncology to Join Major Investor Conferences

Mural Oncology to Join Major Investor Conferences

Mural Oncology to Participate in Major Investor Conferences

Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company, has announced its involvement in two important investor conferences. At these events, the management team will engage with stakeholders through presentations and one-on-one meetings. Key executives will share insights into the company's innovative, investigational engineered cytokine therapies, which aim to meet critical medical needs in the oncology sector.

Upcoming Conferences

At the Morgan Stanley 22nd Annual Global Healthcare Conference, Caroline Loew, Ph.D., the CEO, will join a fireside chat with Vicki Goodman, MD, Chief Medical Officer, and Adam Cutler, Chief Financial Officer. This engaging discussion is set for Friday, September 6, at 1:50 p.m. ET.

H.C. Wainwright 26th Annual Global Investment Conference

Mural Oncology will also take part in the H.C. Wainwright 26th Annual Global Investment Conference. During this event, CEO Caroline Loew, Ph.D., will present the company’s progress and future plans. This presentation is scheduled for Wednesday, September 11, at 9:30 a.m. ET.

About Mural Oncology

Mural Oncology is leading the way in developing groundbreaking immunotherapies through its advanced protein engineering platform. The company combines deep expertise in cytokine biology and immune cell modulation to create treatments that provide significant clinical benefits for cancer patients. Their leading candidate, nemvaleukin, is currently advancing through potentially registrational trials targeting mucosal melanoma and platinum-resistant ovarian cancer.

Mission and Vision

Mural Oncology's mission is clear: to enhance the potential and accessibility of cytokine-based immunotherapies, ultimately improving the quality of life for cancer patients. Their dedication to innovative research and development establishes Mural Oncology as a frontrunner in the battle against cancer.

Corporate Information

The registered office of Mural Oncology is situated in Dublin, Ireland, while its primary facilities are located in Waltham, Massachusetts. The company's ongoing research efforts in oncology underscore their commitment to patient care and the development of innovative treatment options.

Contact Information

For further inquiries, please reach out to:

Katie Sullivan
Email: katie.sullivan@muraloncology.com

Frequently Asked Questions

What is the focus of Mural Oncology?

Mural Oncology is dedicated to developing novel immuno-oncology therapies designed to treat various types of cancer using engineered cytokines.

What are the dates of the upcoming conferences?

The Morgan Stanley Annual Global Healthcare Conference will take place on September 6, and the H.C. Wainwright Annual Global Investment Conference is scheduled for September 11.

Who will be presenting on behalf of Mural Oncology?

Presentations will be delivered by Caroline Loew, Ph.D., CEO, along with other key members of the management team.

What is nemvaleukin?

Nemvaleukin is Mural Oncology's lead candidate, currently undergoing clinical trials to assess its effectiveness against mucosal melanoma and platinum-resistant ovarian cancer.

How can I learn more about Mural Oncology?

For additional information, visit Mural Oncology’s website or follow the company on their LinkedIn and X profiles.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Pye-Barker's Bold Play in Florida Fire Safety Market

Updated Category News Views 19

A Strategic Spark in Fire Protection Well, here's a move that lights up the fire protection sector. Pye-Barker Fire & Safety, known for being the top dog in U.S. fire safety services, decided to scoop up St. John's Fire Equipment down in Florida. Let's just say, they're not putting out any fires here—more like stoking a strategic blaze. This acquisition positions...

Continue Reading
Hello Group Gears Up for Q3 Earnings Release

Updated Category News Views 46

Anticipation Builds for Hello Group's Q3 Results Time flies when you're watching stocks, and believe me, December's about to get red hot for Hello Group Inc. (NASDAQ: MOMO). With their unaudited financial results for the third quarter of 2026 hitting the wire before the U.S. markets open on December 7, there's enough speculation cooking to rival a Thanksgiving feast....

Continue Reading
Illinois House Democrats Surge with Historic Gaines

Updated Category News Views 115

Turning the Election Tide in Illinois Damn, if you're not paying attention to what's shaking in Illinois, it's time to listen up. The Democrats under Speaker Emanuel "Chris" Welch are strutting their stuff, leaving an indelible mark on the political landscape. An eye-popping $35 million in campaign dough was raised, safeguarding every Democratic incumbent and managing to...

Continue Reading
Xinjiang Co-op Elevates Walnut Farmers, Markets Expand

Updated Category News Views 93

From the Gobi Desert to the Global Market You ever hear about walnuts from the Gobi Desert? It sounds like a tale spun over too many drinks, but here we are, talking about folks in Xinjiang crafting an empire out of nuts. Not just any nuts, mind you—walnuts, lovingly nurtured under the sun and cold nights in Kuqa. They’ve carved out a niche in a corner of the world...

Continue Reading
Pharmaceutical Navigator ASTHO's Podcast Earns Bronze Anthem Award

Updated Category News Views 25

An Award to Nod At: ASTHO's Public Health Triumph The world of public health isn't generally where you'd find shiny accolades flying around, but when they do, it's worth taking notice. Recently, ASTHO’s podcast, the Public Health Review Morning Edition, snagged a Bronze Anthem Award. Sure, it isn't the gold trophy, but in this high-stakes arena, any medal's a feat! More...

Continue Reading
Qfin Holdings Faces Class Action Over Stock Drop

Updated Category News Views 122

Qfin Holdings' Troubled Waters Look, when a stock tanks by nearly 19% overnight, it isn't because of some fluke. And that's precisely what's got Qfin Holdings, Inc. investors gritting their teeth and lawyers sharpening their pencils. Deep Dive into Allegations For those keeping score, we're talking about serious allegations here: between March 18, 2026, and August 25,...

Continue Reading
NSING's Bluetooth Milestone: A Signal for Investors

Updated Category News Views 135

The Bluetooth Bonanza: NSING Technologies' Big Win Amidst the bustling lanes of the semiconductor sector, NSING Technologies just threw down a whopper of an announcement—over 250 million Bluetooth chips shipped, all well-knitted with Ceva's technology. This isn’t just another milestone; it's a clarion call for anyone keeping an eye on the evolving landscape of...

Continue Reading
Mondego Bio Charges Ahead with Cancer Therapy Trials

Updated Category News Views 78

Cracking Cancer's Code: Mondego's Bold Move Big news from Portugal today—a quiet town called Cantanhede is now the epicenter of a potential game-changer in cancer therapy. Mondego Bio, with its small-molecule innovator MB?388, is diving headfirst into a Phase 1 clinical study. If you're scratching your head about the significance, let me spell it out: this is an attempt...

Continue Reading
Coronation Securities: Pioneering Digital Brokerage in Nigeria

Updated Category News Views 30

Coronation Securities: A Digital Revolution Ah, Nigerian financial markets have found themselves a trailblazer, folks. Meet Coronation Securities Limited, recently crowned the 'Fastest Growing Digital Brokerage Platform – Nigeria' at the 2026 Global Brand Awards. Now, that's a nod from Global Brands Magazine worth sitting up for. Turning the Tide with Tech In an...

Continue Reading
BDX Flexes Financial Muscle with Strong FY26 Results

Updated Category News Views 56

BD's Performance in FY2026: A Strong Finish Y'know, it's not every day we see a giant like Becton, Dickinson and Company (NYSE: BDX) grinding out some impressive numbers. But, here we are. They just wrapped up fiscal 2026, and it's looking like they ain't just skating by. We're talking a 5.4% bump in fourth quarter revenue, landing them at a cool $5.3 billion. Not too...

Continue Reading

Top 5 Most Recently Viewed Articles

Axsome Therapeutics Showcases Innovations at Major Neuroscience Event

Updated Category News Views 89

Axsome Therapeutics Makes Waves with New Data Presentations Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a leading biopharmaceutical company committed to addressing central nervous system (CNS) disorders through innovative therapies. Recently, the company presented pivotal data at a major neuroscience congress, drawing attention to its extensive portfolio aimed at...

Continue Reading
Synopsys Sells Optical Solutions Group to Keysight Technologies

Updated Category News Views 64

Synopsys Transfers Its Optical Solutions Group to Keysight Technologies In a major development, Synopsys, Inc. (NASDAQ: SNPS) has revealed plans to sell its Optical Solutions Group (OSG) to Keysight Technologies, Inc. This transaction is being made under undisclosed terms and highlights Synopsys' focus on strategic initiatives within the optical design field. Agreement...

Continue Reading
aelf and Gaia Partner for the Groundbreaking Hello [AI] Event

Updated Category News Views 109

aelf and Gaia Join Forces for Hello [AI] Event Get ready to kick off TOKEN2049 week with aelf's exciting AI-themed event, featuring notable AI and Web3 projects such as Gaia, NEAR, Schelling AI, and Sapien. aelf, a prominent Layer 1 blockchain network enhanced by AI, is thrilled to host Hello [AI], a dynamic event that marks the beginning of TOKEN2049 week. This...

Continue Reading
Tronsmart Mirtune H1: The Perfect Outdoor Sound Companion

Updated Category News Views 92

Tronsmart Mirtune H1: Perfect for Outdoor Adventures Tronsmart introduces an exciting new product for outdoor enthusiasts, the Mirtune H1, a portable speaker that promises to deliver vibrant sound regardless of its compact size. This speaker is not just about being small; it's engineered to provide powerful audio experiences whether you're inside enjoying the comfort of...

Continue Reading
Momcozy Revolutionizes Motherhood Fashion at NYFW Event

Updated Category News Views 402

Momcozy made waves at New York Fashion Week (NYFW) back in 2024 by unveiling its game-changing Maternity Wear Collection. This isn’t just any collection; it’s an entire shift in how the fashion industry perceives modern motherhood. At their exclusive Momcozy Lounge, they introduced not only stylish apparel but also the revolutionary Momcozy M9 Mobile Flow™...

Continue Reading